MSH2 and urinary bladder cancer: MMR variants were more common in UTUC, with 27% (<i>n</i> = 101) harboring an <i>MSH2</i> variant compared with 7.6% (<i>n</i> = 109) of bladder cancer patients (<i>p</i> < 0.001).